Technologies segment overview
Dentsply Sirona’s (XRAY) technologies segment is responsible for the manufacture, distribution, and sale of dental implants, imaging systems, treatment centers, orthodontic products, and computer aided design and machining systems.
The segment’s sales represented ~47% of the company’s total sales in 2015.
In 1Q16, Dentsply Sirona’s technologies segment registered net sales of around $284 million, representing constant currency sales growth of ~9.6%. Its internal sales growth was ~6.8%. This compared to the segment’s constant currency sales growth and internal sales growth of ~0.8% each in 1Q15.
All geographic regions reported strong revenue growth in the technologies segment, led by sales in the United States. The segment’s sales growth in 1Q16 was driven by the Dentsply and Sirona merger. The segment also saw savings from the implementation of its global efficiency program. The strong US dollar negatively impacted the segment’s sales growth by around 2.3%.
Dentsply Sirona has a strong product portfolio in the technologies segment. Its computer aided design and machining systems have a strong history dating back over 30 years.
Some of the segment’s key products include the implant brand XIVE, the Ankylos and Astra Tech Implant systems, 3D X-ray products such as the CBCT Galileos Comfort Plus, orthodontic products such as elastics, archwires, and clear aligners, and digital solutions.
Dentsply Sirona’s treatment centers Teneo, Sinius, and Intego are well-known brands in the industry.
Some of the competitors of Dentsply Sirona in the United States include Zimmer Biomet Holdings (ZBH), Cantel Medical (CMN), and Align Technology (ALGN). Dentsply Sirona accounts for ~0.19% of the holdings of the Guggenheim S&P 500 Equal Weight ETF (RSP).